These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 35207255)

  • 41. Novel pathogenic variant combination in
    Shi H; Wang Z
    Transl Pediatr; 2022 Oct; 11(10):1717-1725. PubMed ID: 36345447
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of antisense oligonucleotide therapy against apolipoprotein-CIII in hypertriglyceridemia.
    Gouni-Berthold I
    Atheroscler Suppl; 2017 Nov; 30():19-27. PubMed ID: 29096837
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy and safety of the apolipoprotein C-III inhibitor Volanesorsen: a systematic evaluation and meta-analysis.
    Cheng Y; Li T; Tan P; Du Y; Huang Z; Shi H; Cai T; Chen Y; Fu W
    Endocrine; 2022 May; 76(2):253-262. PubMed ID: 35298785
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of the DGAT1 inhibitor pradigastat on triglyceride and apoB48 levels in patients with familial chylomicronemia syndrome.
    Meyers CD; Tremblay K; Amer A; Chen J; Jiang L; Gaudet D
    Lipids Health Dis; 2015 Feb; 14():8. PubMed ID: 25889044
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of primary hypertriglyceridemia states--General approach and the role of extracorporeal methods.
    Stefanutti C; Julius U
    Atheroscler Suppl; 2015 May; 18():85-94. PubMed ID: 25936310
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Spectrum of Mutations and Long-Term Clinical Outcomes in Genetic Chylomicronemia Syndromes.
    D'Erasmo L; Di Costanzo A; Cassandra F; Minicocci I; Polito L; Montali A; Ceci F; Arca M
    Arterioscler Thromb Vasc Biol; 2019 Dec; 39(12):2531-2541. PubMed ID: 31619059
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy and Safety of Volanesorsen (ISIS 304801): the Evidence from Phase 2 and 3 Clinical Trials.
    Fogacci F; Norata GD; Toth PP; Arca M; Cicero AFG
    Curr Atheroscler Rep; 2020 May; 22(5):18. PubMed ID: 32458077
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Symptoms and impacts of familial chylomicronemia syndrome: a qualitative study of the patient experience.
    Williams K; Tickler G; Valdivielso P; Alonso J; Vera-Llonch M; Cubells L; Acaster S
    Orphanet J Rare Dis; 2023 Oct; 18(1):316. PubMed ID: 37817256
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Volanesorsen to treat severe hypertriglyceridaemia: A pooled analysis of randomized controlled trials.
    Calcaterra I; Lupoli R; Di Minno A; Di Minno MND
    Eur J Clin Invest; 2022 Nov; 52(11):e13841. PubMed ID: 35851450
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Familial chylomicronemia syndrome: A rare but devastating autosomal recessive disorder characterized by refractory hypertriglyceridemia and recurrent pancreatitis.
    Chyzhyk V; Brown AS
    Trends Cardiovasc Med; 2020 Feb; 30(2):80-85. PubMed ID: 31003756
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy and safety of volanesorsen in patients with multifactorial chylomicronaemia (COMPASS): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.
    Gouni-Berthold I; Alexander VJ; Yang Q; Hurh E; Steinhagen-Thiessen E; Moriarty PM; Hughes SG; Gaudet D; Hegele RA; O'Dea LSL; Stroes ESG; Tsimikas S; Witztum JL;
    Lancet Diabetes Endocrinol; 2021 May; 9(5):264-275. PubMed ID: 33798466
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Updates in Drug Treatment of Severe Hypertriglyceridemia.
    Gouni-Berthold I; Schwarz J; Berthold HK
    Curr Atheroscler Rep; 2023 Oct; 25(10):701-709. PubMed ID: 37642858
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Therapeutic apheresis for severe hypertriglyceridemia in pregnancy.
    Basar R; Uzum AK; Canbaz B; Dogansen SC; Kalayoglu-Besisik S; Altay-Dadin S; Aral F; Ozbey NC
    Arch Gynecol Obstet; 2013 May; 287(5):839-43. PubMed ID: 23479052
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular basis of the familial chylomicronemia syndrome in patients from the National Dyslipidemia Registry of the Spanish Atherosclerosis Society.
    Ariza MJ; Rioja J; Ibarretxe D; Camacho A; Díaz-Díaz JL; Mangas A; Carbayo-Herencia JA; Ruiz-Ocaña P; Lamíquiz-Moneo I; Mosquera D; Sáenz P; Masana L; Muñiz-Grijalvo O; Pérez-Calahorra S; Valdivielso P;
    J Clin Lipidol; 2018; 12(6):1482-1492.e3. PubMed ID: 30150141
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hospital Management of Severe Hypertriglyceridemia in Children.
    Valaiyapathi B; Ashraf AP
    Curr Pediatr Rev; 2017; 13(4):225-231. PubMed ID: 29345595
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gene Therapy in Lipoprotein Lipase Deficiency: Case Report on the First Patient Treated with Alipogene Tiparvovec Under Daily Practice Conditions.
    Kassner U; Hollstein T; Grenkowitz T; Wühle-Demuth M; Salewsky B; Demuth I; Dippel M; Steinhagen-Thiessen E
    Hum Gene Ther; 2018 Apr; 29(4):520-527. PubMed ID: 29641318
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Development of Antisense Oligonucleotide Gapmers for the Treatment of Dyslipidemia and Lipodystrophy.
    Aslesh T; Yokota T
    Methods Mol Biol; 2020; 2176():69-85. PubMed ID: 32865783
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Incidental finding of severe hypertriglyceridemia in children. Role of multiple rare variants in genes affecting plasma triglyceride.
    Buonuomo PS; Rabacchi C; Macchiaiolo M; Trenti C; Fasano T; Tarugi P; Bartuli A; Bertolini S; Calandra S
    J Clin Lipidol; 2017; 11(6):1329-1337.e3. PubMed ID: 28951076
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Analysis of a Chinese Pedigree With Familial Chylomicronemia Syndrome Reveals Two Novel
    Liu Y; Lan Z; Zhao F; Zhang S; Zhang W
    Front Genet; 2020; 11():741. PubMed ID: 32765589
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Severe Hypertriglyceridaemia and Chylomicronaemia Syndrome-Causes, Clinical Presentation, and Therapeutic Options.
    Bashir B; Ho JH; Downie P; Hamilton P; Ferns G; Datta D; Cegla J; Wierzbicki AS; Dawson C; Jenkinson F; Delaney H; Mansfield M; Teoh Y; Miedzybrodzka Z; Haso H; Durrington PN; Soran H
    Metabolites; 2023 Apr; 13(5):. PubMed ID: 37233662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.